MedPath

Detection of recurrent head and neck tumours after chemoradiation with a tumor-sensitive MRI technique.

Recruiting
Conditions
squamous cell carcinoma, recurrence, radiotherapyplaveiselcelcarcinoom, recidief, radiotherapie
Registration Number
NL-OMON29514
Lead Sponsor
niversity Medical Center Utrecht (UMCU), Department if ENT
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
75
Inclusion Criteria

1. Patients with a oropharyngeal, hypopharyngeal, or laryngeal squamous cell carcinoma treated with (chemo)radiation with curative intent;

2. A clinical suspicion of a recurrence;

Exclusion Criteria

1. Patients with contraindication for MRI or contrast agent;

2. Patients who received salvage surgery for the primary lesion;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The diagnostic performance of DW-MRI for the detection of recurrence in patients with clinical suspicion of recurrent or persistent HNSCC after initial (chemo) radiation will be primarily reflected by the PPV of DW-MRI. Furthermore, the NPV, discrimination, sensitivity and specificity will be assessed.
Secondary Outcome Measures
NameTimeMethod
1. Number of futile biopsies with DW-MRI as selection strategy for endoscopy with taking of biopsies;<br /><br>2. Discordant pairs (Regular imaging vs. DW-MRI);<br /><br>3. Number of missed cases by DW-MRI compared to regular imaging;<br /><br>4. Number of extra cases detected by DW-MRI compared to regular imaging.
© Copyright 2025. All Rights Reserved by MedPath